RT Journal Article
SR Electronic
T1 Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007366
DO 10.1136/jitc-2023-007366
VO 11
IS 9
A1 Zhang, Wenwen
A1 Tong, Shuang
A1 Hu, Bingyang
A1 Wan, Tao
A1 Tang, Haowen
A1 Zhao, Feilong
A1 Jiao, Tianyu
A1 Li, Junfeng
A1 Zhang, Ze
A1 Cai, Jinping
A1 Ye, Huiyi
A1 Wang, Zhanbo
A1 Chen, Shiqing
A1 Wang, Yafei
A1 Li, Xuerui
A1 Wang, Fangzhou
A1 Cao, Junning
A1 Tian, Lantian
A1 Zhao, Xiaochen
A1 Chen, Mingyi
A1 Wang, Hongguang
A1 Cai, Shouwang
A1 Hu, Minggen
A1 Bai, Yuezong
A1 Lu, Shichun
YR 2023
UL http://jitc.bmj.com/content/11/9/e007366.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.